These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 31171998)

  • 1. Histopathologic Assessment of Optic Nerves and Retina From a Patient With Chronically Implanted Argus II Retinal Prosthesis System.
    Lin TC; Wang LC; Yue L; Zhang Y; Falabella P; Zhu D; Hinton DR; Rao NA; Birch DG; Spencer R; Dorn JD; Humayun MS
    Transl Vis Sci Technol; 2019 May; 8(3):31. PubMed ID: 31171998
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Morphometric analysis of optic nerves and retina from an end-stage retinitis pigmentosa patient with an implanted active epiretinal array.
    Eng JG; Agrawal RN; Tozer KR; Ross-Cisneros FN; Dagnelie G; Greenberg RJ; Chader GJ; Weiland JD; Rao NA; Sadun AA; Humayun MS
    Invest Ophthalmol Vis Sci; 2011 Jun; 52(7):4610-6. PubMed ID: 21296811
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Five-Year Safety and Performance Results from the Argus II Retinal Prosthesis System Clinical Trial.
    da Cruz L; Dorn JD; Humayun MS; Dagnelie G; Handa J; Barale PO; Sahel JA; Stanga PE; Hafezi F; Safran AB; Salzmann J; Santos A; Birch D; Spencer R; Cideciyan AV; de Juan E; Duncan JL; Eliott D; Fawzi A; Olmos de Koo LC; Ho AC; Brown G; Haller J; Regillo C; Del Priore LV; Arditi A; Greenberg RJ;
    Ophthalmology; 2016 Oct; 123(10):2248-54. PubMed ID: 27453256
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the Long-Term Clinical Results of 3 Patients Implanted with the Argus II Retinal Prosthesis.
    Güven D; Düzgün E; Kutucu OK; Gül C
    Turk J Ophthalmol; 2023 Feb; 53(1):58-66. PubMed ID: 36847635
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-Term Results from an Epiretinal Prosthesis to Restore Sight to the Blind.
    Ho AC; Humayun MS; Dorn JD; da Cruz L; Dagnelie G; Handa J; Barale PO; Sahel JA; Stanga PE; Hafezi F; Safran AB; Salzmann J; Santos A; Birch D; Spencer R; Cideciyan AV; de Juan E; Duncan JL; Eliott D; Fawzi A; Olmos de Koo LC; Brown GC; Haller JA; Regillo CD; Del Priore LV; Arditi A; Geruschat DR; Greenberg RJ;
    Ophthalmology; 2015 Aug; 122(8):1547-54. PubMed ID: 26162233
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retinal Anatomy and Electrode Array Position in Retinitis Pigmentosa Patients After Argus II Implantation: An International Study.
    Gregori NZ; Callaway NF; Hoeppner C; Yuan A; Rachitskaya A; Feuer W; Ameri H; Arevalo JF; Augustin AJ; Birch DG; Dagnelie G; Grisanti S; Davis JL; Hahn P; Handa JT; Ho AC; Huang SS; Humayun MS; Iezzi R; Jayasundera KT; Kokame GT; Lam BL; Lim JI; Mandava N; Montezuma SR; Olmos de Koo L; Szurman P; Vajzovic L; Wiedemann P; Weiland J; Yan J; Zacks DN
    Am J Ophthalmol; 2018 Sep; 193():87-99. PubMed ID: 29940167
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long term positional stability of the Argus II retinal prosthesis epiretinal implant.
    Ghani N; Bansal J; Naidu A; Chaudhary KM
    BMC Ophthalmol; 2023 Feb; 23(1):70. PubMed ID: 36797684
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retina-electrode interface properties and vision restoration by two generations of retinal prostheses in one patient-one in each eye.
    Yue L; Wuyyuru V; Gonzalez-Calle A; Dorn JD; Humayun MS
    J Neural Eng; 2020 Apr; 17(2):026020. PubMed ID: 32131056
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of the electrode array-retina gap distance on visual function in patients with the Argus II retinal prosthesis.
    Naidu A; Ghani N; Yazdanie MS; Chaudhary K
    BMC Ophthalmol; 2020 Sep; 20(1):366. PubMed ID: 32943044
    [TBL] [Abstract][Full Text] [Related]  

  • 10. One-Year Anatomical and Functional Outcomes of the Argus II Implantation in Korean Patients with Late-Stage Retinitis Pigmentosa: A Prospective Case Series Study.
    Yoon YH; Humayun MS; Kim YJ
    Ophthalmologica; 2021; 244(4):291-300. PubMed ID: 33279905
    [TBL] [Abstract][Full Text] [Related]  

  • 11. OPTOMAP WIDEFIELD IMAGING OF THE ARGUS II RETINAL PROSTHESIS IN PATIENTS WITH RETINITIS PIGMENTOSA.
    Israelsen PE; Sadda SR; Dorn JD; Humayun MS; Olmos de Koo LC
    Retin Cases Brief Rep; 2016; 10(4):382-5. PubMed ID: 26705237
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Feasibility of Structural and Functional MRI Acquisition with Unpowered Implants in Argus II Retinal Prosthesis Patients: A Case Study.
    Cunningham SI; Shi Y; Weiland JD; Falabella P; Olmos de Koo LC; Zacks DN; Tjan BS
    Transl Vis Sci Technol; 2015 Dec; 4(6):6. PubMed ID: 26693097
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retinal Prosthesis System for Advanced Retinitis Pigmentosa: A Health Technology Assessment.
    Health Quality Ontario
    Ont Health Technol Assess Ser; 2016; 16(14):1-63. PubMed ID: 27468325
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Retinal Prosthesis System for Advanced Retinitis Pigmentosa: A Health Technology Assessment Update.
    Health Quality Ontario
    Ont Health Technol Assess Ser; 2017; 17(13):1-62. PubMed ID: 29201260
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improved performance and safety from Argus II retinal prosthesis post-approval study in France.
    Delyfer MN; Gaucher D; Mohand-Saïd S; Barale PO; Rezaigua-Studer F; Ayello-Scheer S; Dollfus H; Dorn JD; Korobelnik JF; Sahel JA
    Acta Ophthalmol; 2021 Nov; 99(7):e1212-e1221. PubMed ID: 33354943
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optical coherence tomography imaging in the management of the Argus II retinal prosthesis system.
    Parmeggiani F; De Nadai K; Piovan A; Binotto A; Zamengo S; Chizzolini M
    Eur J Ophthalmol; 2017 Jan; 27(1):e16-e21. PubMed ID: 28009400
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term histological and electrophysiological results of an inactive epiretinal electrode array implantation in dogs.
    Majji AB; Humayun MS; Weiland JD; Suzuki S; D'Anna SA; de Juan E
    Invest Ophthalmol Vis Sci; 1999 Aug; 40(9):2073-81. PubMed ID: 10440263
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of the Argus II Retinal Prosthesis System on the Quality of Life of Patients With Ultra-Low Vision Due to Retinitis Pigmentosa: Protocol for a Single-Arm, Mixed Methods Study.
    White J; Knight L; da Cruz L; Stanga PE; Patrick H; Powell H; Berry L; Withers K; Carolan-Rees G; Jackson TL
    JMIR Res Protoc; 2021 Jan; 10(1):e17436. PubMed ID: 33470946
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endoscope-Assisted and Controlled Argus II Epiretinal Prosthesis Implantation in Late-Stage Retinitis Pigmentosa: A Report of 2 Cases.
    Özmert E; Demirel S
    Case Rep Ophthalmol; 2016; 7(3):315-324. PubMed ID: 28203188
    [TBL] [Abstract][Full Text] [Related]  

  • 20. One-Year Safety and Performance Assessment of the Argus II Retinal Prosthesis: A Postapproval Study.
    Schaffrath K; Schellhase H; Walter P; Augustin A; Chizzolini M; Kirchhof B; Grisanti S; Wiedemann P; Szurman P; Richard G; Greenberg RJ; Dorn JD; Parmeggiani F; Rizzo S
    JAMA Ophthalmol; 2019 Aug; 137(8):896-902. PubMed ID: 31145440
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.